BioCentury
ARTICLE | Company News

Gilead, Glaxo Wellcome Inc. deal

July 31, 1995 7:00 AM UTC

GILD (Foster City, Calif.) extended for six months its agreement with Glaxo Wellcome to devlop genetic code blocker technology. Glaxo Wellcome will make a $1.25 million payment to GILD to fund researc...